看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 944.1x - 1,043.5x | 993.8x |
| Selected Fwd EBITDA Multiple | 10.3x - 11.4x | 10.9x |
| Fair Value | €5.96 - €6.58 | €6.27 |
| Upside | -6.5% - 3.4% | -1.5% |
| Benchmarks | Ticker | Full Ticker |
| OmniAb, Inc. | OABI | NasdaqGM:OABI |
| WuXi Biologics (Cayman) Inc. | 1FW2 | DB:1FW2 |
| IQVIA Holdings Inc. | QTS | DB:QTS |
| Adaptive Biotechnologies Corporation | 1HM | MUN:1HM |
| Charles River Laboratories International, Inc. | RV6 | DB:RV6 |
| Evotec SE | EVT | DB:EVT |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| OABI | 1FW2 | QTS | 1HM | RV6 | EVT | ||
| NasdaqGM:OABI | DB:1FW2 | DB:QTS | MUN:1HM | DB:RV6 | DB:EVT | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | NM- | 37.4% | 9.2% | NM- | 8.9% | -64.1% | |
| 3Y CAGR | NM- | 15.5% | 5.3% | NM- | -0.1% | -80.6% | |
| Latest Twelve Months | -7.1% | 13.2% | 7.4% | 24.1% | -7.0% | -99.1% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | -107.1% | 31.6% | 17.7% | -110.8% | 23.9% | 12.6% | |
| Prior Fiscal Year | -145.6% | 28.9% | 18.2% | -105.3% | 23.4% | 9.2% | |
| Latest Fiscal Year | -201.9% | 29.9% | 19.0% | -76.0% | 22.2% | 0.1% | |
| Latest Twelve Months | -201.9% | 29.9% | 19.0% | -76.0% | 22.2% | 0.1% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 6.91x | 3.94x | 2.47x | 5.90x | 1.88x | 1.43x | |
| EV / LTM EBITDA | -3.4x | 13.2x | 13.0x | -7.8x | 8.5x | 1745.6x | |
| EV / LTM EBIT | -2.4x | 16.0x | 16.7x | -6.8x | 14.0x | -14.4x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -7.8x | 8.5x | 13.2x | ||||
| Historical EV / LTM EBITDA | 31.7x | 60.6x | 1745.6x | ||||
| Selected EV / LTM EBITDA | 944.1x | 993.8x | 1043.5x | ||||
| (x) LTM EBITDA | 1 | 1 | 1 | ||||
| (=) Implied Enterprise Value | 615 | 647 | 679 | ||||
| (-) Non-shareholder Claims * | (0) | (0) | (0) | ||||
| (=) Equity Value | 614 | 646 | 679 | ||||
| (/) Shares Outstanding | 177.6 | 177.6 | 177.6 | ||||
| Implied Value Range | 3.46 | 3.64 | 3.82 | ||||
| FX Rate: EUR/EUR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 3.46 | 3.64 | 3.82 | 6.37 | |||
| Upside / (Downside) | -45.7% | -42.8% | -40.0% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | OABI | 1FW2 | QTS | 1HM | RV6 | EVT | |
| Enterprise Value | 182 | 72,623 | 37,742 | 1,404 | 7,569 | 1,131 | |
| (+) Cash & Short Term Investments | 59 | 10,710 | 1,843 | 222 | 195 | 397 | |
| (+) Investments & Other | 0 | 2,400 | 374 | 34 | 218 | 42 | |
| (-) Debt | (23) | (4,940) | (14,484) | (223) | (2,781) | (439) | |
| (-) Other Liabilities | 0 | (3,658) | 0 | 0 | (47) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 219 | 77,134 | 25,475 | 1,438 | 5,154 | 1,131 | |
| (/) Shares Outstanding | 122.1 | 4,047.8 | 176.3 | 172.1 | 49.1 | 177.6 | |
| Implied Stock Price | 1.79 | 19.06 | 144.48 | 8.36 | 104.95 | 6.37 | |
| FX Conversion Rate to Trading Currency | 1.00 | 8.32 | 1.14 | 1.14 | 1.14 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1.79 | 2.29 | 126.80 | 7.33 | 92.10 | 6.37 | |
| Trading Currency | USD | EUR | EUR | EUR | EUR | EUR | |
| FX Rate to Reporting Currency | 1.00 | 8.32 | 1.14 | 1.14 | 1.14 | 1.00 | |